Metabolomic profiles discriminating anxiety from depression

Area of Science:

• Metabolomics
• Psychiatry
• Biochemistry

Background:

• Depression and anxiety disorders frequently co-occur and may share underlying causes.
• Metabolomic alterations have been observed in individuals with depression.
• The distinct metabolomic profiles between depression and anxiety disorders remain unclear.

Purpose of the Study:

• To investigate differential metabolomic alterations between anxiety and depressive disorders.
• To identify clinical characteristics of these disorders associated with metabolomic changes.

Main Methods:

• Utilized data from the Netherlands Study of Depression and Anxiety (NESDA).
• Analyzed 40 metabolites using a proton nuclear magnetic resonance lipid-based metabolomics panel.
• Compared metabolite levels across groups: comorbid anxiety/depression, depression-only, anxiety-only, remitted disorders, and healthy controls.

Main Results:

• Individuals with depression (alone or comorbid) showed altered inflammatory and atherogenic-lipoprotein-related metabolite profiles compared to controls.
• No significant metabolomic alterations were found in individuals with anxiety disorder only.
• Depression severity, not anxiety severity or duration, correlated with most depression-associated metabolite changes.

Conclusions:

• Altered inflammatory and atherogenic-lipoprotein-related metabolomic profiles are uniquely associated with depression, not anxiety disorders.
• These findings suggest distinct biological pathways for depression and anxiety, despite clinical overlap.